Can a transplant drug boost heart health in the elderly?
NCT ID NCT04742777
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether rapamycin, a drug used to prevent transplant rejection, can improve heart function in healthy adults aged 70-95. Researchers used MRI scans to measure changes in heart pumping and blood vessel flexibility after 8 weeks of treatment. The goal was to see if this drug could help manage age-related declines in heart health.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AGING are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Audie L. Murphy Memorial Veterans Hospital
San Antonio, Texas, 78229, United States
-
The University of Texas Health Science Center at San Antonio
San Antonio, Texas, 78229, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could your heart hold the key to Alzheimer's prevention?
- The aging Body's hidden water shift: a new study investigates
- Rewiring the veteran brain: could visual training counteract cognitive decline?
- Can a simple walk test reveal hidden health risks in aging?
- A handful of walnuts a day: could it keep the aging mind sharp?
- Shining a light on brain aging: could NIR boost memory?